Evidence map›Paper›PMID 34789768›Full record

ArticleNature communications2021

RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination.

Qian Zhu, Jinzhou Huang, Hongyang Huang, Huan Li, Peiqiang Yi, Jake A Kloeber, Jian Yuan, Yuping Chen, Min Deng, Kuntian Luo and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Qian Zhu *Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.ORCID http://orcid.org/0000-0001-6277-0965
Jinzhou Huang *Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0002-5956-0905
Hongyang HuangDepartment of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, 999077, China.ORCID http://orcid.org/0000-0002-5138-7781
Huan LiDepartment of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Peiqiang YiDepartment of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Jake A KloeberDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0002-6646-564X
Jian YuanResearch Center for Translational Medicine, East Hospital, Tongji University School of medicine, Shanghai, 200120, China.ORCID http://orcid.org/0000-0002-2801-8849
Yuping ChenResearch Center for Translational Medicine, East Hospital, Tongji University School of medicine, Shanghai, 200120, China.
Min DengDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0003-1987-9775
Kuntian LuoDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Ming GaoDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Guijie GuoDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Xinyi TuDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Ping YinDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Yong ZhangDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Jun SuDepartment of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Jiayi ChenDepartment of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China. chenjiayi0188@aliyun.com.ORCID http://orcid.org/0000-0001-6417-290X
Zhenkun LouDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA. Lou.Zhenkun@mayo.edu.ORCID http://orcid.org/0000-0003-1938-3091

Funding

Medical Scientist Traning Program at Mayo ClinicT32GM065841 · NIGMS · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H, SCHIMMENTI, LISA A · 2003 to 2022
$5.8M
NIGMS NIH HHS T32 GM065841
6 · The paper itself

Abstract

BRCA1-BARD1 heterodimers act in multiple steps during homologous recombination (HR) to ensure the prompt repair of DNA double strand breaks. Dysfunction of the BRCA1 pathway enhances the therapeutic efficiency of poly-(ADP-ribose) polymerase inhibitors (PARPi) in cancers, but the molecular mechanisms underlying this sensitization to PARPi are not fully understood. Here, we show that cancer cell sensitivity to PARPi is promoted by the ring between ring fingers (RBR) protein RNF19A. We demonstrate that RNF19A suppresses HR by ubiquitinating BARD1, which leads to dissociation of BRCA1-BARD1 complex and exposure of a nuclear export sequence in BARD1 that is otherwise masked by BRCA1, resulting in the export of BARD1 to the cytoplasm. We provide evidence that high RNF19A expression in breast cancer compromises HR and increases sensitivity to PARPi. We propose that RNF19A modulates the cancer cell response to PARPi by negatively regulating the BRCA1-BARD1 complex and inhibiting HR-mediated DNA repair.

Indexed as

Homologous RecombinationUbiquitinationBRCA1 ProteinBreast NeoplasmsCarcinogenesisDNA DamageFemaleHumansPoly(ADP-ribose) Polymerase InhibitorsProtein BindingProtein MultimerizationRING Finger DomainsTumor Suppressor ProteinsUbiquitin-Protein LigasesBARD1 protein, humanBRCA1 ProteinBRCA1 protein, humanPoly(ADP-ribose) Polymerase InhibitorsRNF19A protein, humanTumor Suppressor ProteinsUbiquitin-Protein Ligases

Identifiers

PMID34789768
PMCPMC8599684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.